Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. After obtaining approval to issue convertible corporate bonds to unspecified targets, the company continued to advance the issuance of convertible corporate bonds to unspecified targets. Due to changes in various factors such as the timing of issuance, the company failed to implement the issuance of convertible corporate bonds to unspecified targets during the validity period of the approval, and the approval automatically expired when it expired.

Construction of this project to raise capital by issuing convertible corporate bonds to unspecified targets officially began in September 2023, and the company will continue to advance the construction of the project as planned by self-financing or other financing methods.